SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-23-007078
Filing Date
2023-03-17
Accepted
2023-03-17 17:03:27
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 vxrt20230316_s3.htm S-3 441934
2 EXHIBIT 4.2 ex_490026.htm EX-4.2 326605
3 EXHIBIT 5.1 ex_490027.htm EX-5.1 40832
4 EXHIBIT 23.3 ex_490028.htm EX-23.3 2814
5 EXHIBIT 107 ex_490025.htm EX-FILING FEES 103703
6 ex_490027img001.jpg GRAPHIC 6681
7 logo01.jpg GRAPHIC 17930
  Complete submission text file 0001437749-23-007078.txt   951305
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-270671 | Film No.: 23743608
SIC: 2836 Biological Products, (No Diagnostic Substances)